NPM Capital is selling its stake in Hendrix Genetics to Paine Schwartz Partners, enabling a 50-50 ownership structure and fostering a strategic partnership aimed at advancing sustainable practices in the animal protein sector.
Information on the Target
Hendrix Genetics, established in 2005 and based in Boxmeer, the Netherlands, is a prominent multi-species animal genetics and technology company. It plays a vital role in the animal protein value chain by offering innovative and sustainable genetic solutions that address global food challenges. The company boasts a diverse set of breeding programs encompassing turkeys, laying hens, traditional poultry, swine, salmon, trout, and shrimp.
Hendrix Genetics operates under a portfolio of 12 esteemed brands, including Hybrid, ISA, Dekalb, and others, employing over 3,500 personnel across its operations in 25 countries. The management team, under the leadership of CEO Jolanda van Haarlem, will continue to drive the company's vision, alongside co-founders Thijs Hendrix and Antoon van den Berg, who will retain a 50% ownership stake and remain actively involved in the company's growth.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The Netherlands is recognized as a global leader in agrifood technology, particularly in sustainable agricultural practices. The country's innovation in animal genetics plays a pivotal role in enhancing
Similar Deals
APG Asset Management → Rival Foods
2025
3i Group plc → Royal Sanders
2023
World Fund and CPT Capital → ENOUGH
2023
Craft Capital → Continental Shellfish Organisation
2021
Paine Schwartz Partners
invested in
Hendrix Genetics
in 2023
in a Growth Equity & Expansion Capital deal